Introduction: Bridging the Gap in CFRD Care

The transition from pediatric to adult healthcare represents one of the most vulnerable periods for patients living with cystic fibrosis (CF) and diabetes. Cystic fibrosis-related diabetes (CFRD) is a distinct form of diabetes that combines features of type 1 and type 2 diabetes, affecting approximately 20% of adolescents and 40-50% of adults with CF. Unlike other forms of diabetes, CFRD requires a nuanced approach to management because of the competing metabolic demands of CF, including high caloric needs and the risk of hypoglycemia due to malabsorption and fluctuating insulin sensitivity.

When patients age out of pediatric care, typically between 18 and 21 years of age, they leave behind a familiar, family-centered care model and enter an adult system that expects greater independence and self-advocacy. This shift can be disruptive, leading to gaps in care, declining lung function, worsening glycemic control, and increased hospitalizations. For healthcare providers, families, and patients alike, a structured, compassionate, and well-coordinated transition strategy is essential. This article explores the challenges of transitioning CFRD patients, offers actionable strategies for each stage of the process, and emphasizes the need for multidisciplinary collaboration to improve long-term outcomes.

What Makes CFRD Unique?

CFRD results from the progressive destruction of pancreatic islet cells due to thick mucus secretions, leading to insulin deficiency. However, unlike type 1 diabetes, patients often retain some endogenous insulin production, and unlike type 2 diabetes, insulin resistance is not the primary defect—though it can occur during acute illness or with glucocorticoid use. CFRD is characterized by postprandial hyperglycemia, unpredictable swings in blood glucose, and a high risk of hypoglycemia, especially in patients who require enteral tube feeding or who have advanced lung disease.

Clinical Implications for Transition-Age Patients

Adolescents and young adults with CFRD face a triple burden: managing a chronic, progressive lung disease, adhering to a complex diabetes regimen, and navigating the psychosocial demands of emerging adulthood. Poor glycemic control in CFRD accelerates the decline in lung function, worsens nutritional status, and increases the risk of infections. During transition, these risks are magnified if care continuity is broken. Research shows that structured transition programs improve adherence to clinic visits, glycemic outcomes, and quality of life.

The Transition Challenge: Why It Is So Difficult

Loss of Familiarity and Trust

Pediatric CF care centers are often small, family-centered, and highly accessible. Patients and families develop deep, trusting relationships with their care team over many years. Adult care centers, by contrast, are typically larger, more fragmented, and less accommodating of family involvement. The loss of this trusted relationship can be disorienting and may cause patients to disengage from care entirely.

Increased Self-Management Demands

In pediatric settings, parents and guardians often take primary responsibility for medication management, appointment scheduling, and monitoring. Adult care expects the patient to manage these tasks independently. For a young adult with CFRD, this means mastering daily insulin injections or pump therapy, carbohydrate counting, continuous glucose monitor (CGM) data interpretation, airway clearance, enzyme dosing, and nutrition planning—all while balancing school, work, and social life. The cognitive and emotional load is substantial.

Communication Gaps Between Care Teams

Transfer of medical records, care plans, and personal knowledge about the patient is often incomplete. Pediatric and adult teams may use different electronic health records, have different clinical protocols, and rarely communicate directly. This fragmentation can result in duplicated tests, medication errors, and loss of important contextual information, such as the patient’s history of hypoglycemia unawareness or adherence barriers.

Preparing for Transition: A Phased Approach

Start Early: The Adolescence Readiness Period

Transition planning should begin no later than age 14 or 15, with gradual increases in patient responsibility. The goal is not to rush independence but to build skills slowly in a supportive environment. During this phase, providers should:

  • Assess the patient’s knowledge of CFRD, including insulin administration, glucose monitoring, and recognition of hypo- and hyperglycemia symptoms.
  • Introduce the concept of transition as a normal, positive milestone rather than a loss of care.
  • Encourage the patient to spend part of each clinic visit alone with the provider, fostering direct communication and self-advocacy.
  • Collaborate with the patient and family to create a written transition plan that outlines timelines, goals, and roles.

Building Self-Management Skills

Self-management is a learned behavior. Use the Transition Readiness Assessment Questionnaire (TRAQ) or a similar tool to identify gaps. Practical skill-building activities include:

  • Medication management: Have the patient refill prescriptions, calculate insulin doses for meals and corrections, and adjust doses based on activity or illness.
  • Monitoring: Teach the patient to download and review their CGM or meter data, identify trends, and communicate findings to their care team.
  • Nutrition: Work with a dietitian to help the patient plan meals that balance high-calorie CF needs with CFRD carbohydrate counting.
  • Scheduling: Practice making appointments, rescheduling, and navigating the adult clinic’s phone system or patient portal.

Facilitating Introductions to Adult Providers

One of the most effective strategies for easing transition anxiety is a structured “meet and greet” between the patient and the adult care team before the official transfer. Ideally, this includes at least one joint appointment where the pediatric and adult providers meet together with the patient and family. This face-to-face handoff signals continuity and trust. If a joint visit is not possible, a warm handoff via phone or video call is a strong alternative.

Educational Support: Empowering Patients with Knowledge

CFRD-Specific Education

Generic diabetes education is insufficient for CFRD. Patients need tailored instruction that addresses the unique interplay between CF and diabetes. Key topics include:

  • Insulin therapy: Why insulin is the primary treatment, how to dose for meals and high-calorie snacks, and how to adjust during acute illness or when using tube feeds.
  • Hypoglycemia prevention: The high frequency of hypoglycemia in CFRD due to erratic absorption and delayed gastric emptying. Patients should know how to use fast-acting glucose and when to contact the care team.
  • Impact on lung health: How high blood glucose impairs immune function and contributes to pulmonary exacerbations. Emphasize that good glycemic control is as important as airway clearance for maintaining lung function.
  • Reproductive health: For patients of childbearing potential, education about preconception planning, contraception, and the increased risks of gestational diabetes in CFRD.

Interactive and Age-Appropriate Resources

Traditional lectures are less effective than interactive, problem-based learning. Use case scenarios, apps, and peer mentoring. The Cystic Fibrosis Foundation offers excellent patient education materials on CFRD. Consider connecting patients with online or in-person support groups specifically for young adults with CFRD. National organizations such as the American Diabetes Association also provide resources that can be adapted for this population.

Nutritional Management: Balancing High Caloric Needs with Glycemic Control

The Challenge of Hyperglycemia and Malnutrition

Patients with CF require 120-150% of the caloric intake of their peers without CF, largely from fat and carbohydrate sources. For a patient with CFRD, this high-carbohydrate diet can cause postprandial hyperglycemia, while intestinal malabsorption can lead to unpredictable glycemic excursions. Nutritional management must be individualized and dynamic.

Practical Strategies for the Transition Period

  • Carbohydrate consistency: Work with a dietitian to determine a consistent carbohydrate intake per meal and snack, and teach the patient to pre-bolus insulin accordingly.
  • Insulin-to-carbohydrate ratios: These ratios may differ significantly from those used in type 1 diabetes due to concurrent use of CFTR modulators, which can improve pancreatic function and alter insulin needs.
  • Tube feeding adjustments: For patients who use enteral feeds, develop a protocol for insulin coverage during continuous or bolus feeds. This should be reviewed during the transition to ensure the adult team understands the patient’s specific regimen.
  • Monitoring trends: CGM is invaluable for identifying patterns related to specific foods, mealtimes, and exercise. Encourage patients to use CGM data to make real-time decisions and share reports with their dietitian and endocrinologist.

Psychological and Emotional Support: The Often-Overlooked Pillar

Mental Health Burden in CFRD

The prevalence of depression and anxiety in people with CF is high, and the addition of diabetes doubles the burden. Young adults face unique stressors: the weight of managing two complex diseases, fear of declining health, and social isolation from peers who do not share their health challenges. Transition itself can trigger grief over the loss of pediatric care and anxiety about the unknown.

Integrating Mental Health into Transition Care

Every transition program should include routine screening for depression and anxiety using validated tools such as the PHQ-9 and GAD-7. Embedded mental health professionals, including psychologists, social workers, and psychiatrists with expertise in chronic illness, should be part of the multidisciplinary team. Strategies include:

  • Peer support groups: Connecting patients with others going through the same transition can reduce isolation. Virtual groups are particularly effective for CF patients who may have infection control restrictions.
  • Mindfulness and stress reduction: Teach simple techniques for managing diabetes-related distress and procedural anxiety.
  • Encouraging self-advocacy: Empower patients to voice their concerns, ask questions, and participate in shared decision-making with their adult care team. Role-playing common scenarios, such as asking for a referral or clarifying a medication change, can build confidence.

Role of Multidisciplinary Teams in Adult Care

Core Team Composition

An effective adult CFRD care team includes:

  • Pulmonologist with expertise in CF
  • Endocrinologist or diabetologist specializing in CFRD
  • Registered dietitian with dual expertise in CF nutrition and diabetes
  • CF nurse coordinator to facilitate communication
  • Mental health professional (psychologist, social worker, or psychiatrist)
  • Certified diabetes care and education specialist (CDCES)

Coordinated care is critical. Weekly or biweekly “huddles” between the pulmonology and endocrinology teams, along with shared electronic health records, can prevent siloed decision-making. The CF Foundation has published guidelines for the care of CFRD that emphasize the importance of this team-based approach.

Warm Handoffs and Structured Transfer Protocols

Adult programs should adopt a standardized transition protocol that includes:

  • A dedicated transition coordinator who tracks progress and ensures follow-up
  • A checklist of required documents (medical summary, growth charts, recent pulmonary function tests, HbA1c trends, CGM reports, and diabetes management plan)
  • A face-to-face introduction between the pediatric and adult providers
  • A scheduled first visit to the adult clinic within 3-6 months of the last pediatric visit, with a low threshold for earlier follow-up if the patient is unstable
  • A mechanism for the pediatric team to provide post-transfer support for the first 12-24 months, such as a phone line or periodic check-ins

Technology and Tools: Leveraging Digital Health for Seamless Care

Continuous Glucose Monitoring (CGM)

CGM is the standard of care for CFRD. Real-time or intermittently scanned CGM systems provide the data needed to adjust insulin doses, prevent severe hypoglycemia, and understand the impact of exercise and illness. During transition, ensure that the patient knows how to share CGM data with both their pulmonology and endocrinology teams. Some platforms, like Dexcom Clarity and Abbott LibreView, allow for remote monitoring by care providers, which can bridge care gaps during the transfer period.

Insulin Pumps

Insulin pump therapy, including hybrid closed-loop systems, can be beneficial for selected patients with CFRD, particularly those with frequent hypoglycemia or high glycemic variability. While not all CFRD patients are candidates, those with good technical skills and motivation may find that pump therapy simplifies management. Transition planning should include an evaluation of pump competency and a plan for pump support in the adult clinic.

Telehealth and Patient Portals

Telehealth visits can reduce the burden of travel for patients who are geographically distant from their adult CF center or who have infection control restrictions. Patient portals enable secure messaging, prescription refill requests, and access to lab results. Teach patients how to use these tools before they leave pediatric care. A 30-minute “portal training” session can dramatically improve engagement after transfer.

Conclusion: Building a Bridge, Not a Handoff

Transition from pediatric to adult care for patients with cystic fibrosis-related diabetes is not a single event but a process that requires early, intentional, and ongoing investment. When done well, it empowers patients to take ownership of their health while maintaining the multidisciplinary support that is essential for managing these complex conditions. The stakes are high: poor transition outcomes are linked to accelerated lung function decline, worsening glycemic control, and increased healthcare utilization. However, with structured preparation, tailored education, integrated mental health support, and a coordinated care team, the transition can be a period of growth and resilience rather than disruption and risk.

Healthcare systems, institutions, and individual providers must prioritize transition readiness as a core quality metric. By treating transition as an essential phase of care rather than an administrative handoff, we can ensure that young adults with CFRD enter adult care with the skills, confidence, and support they need to thrive.

For further reading and resources, visit the Cystic Fibrosis Foundation's CFRD Guidelines, the American Diabetes Association, and the CDC's guidance on pediatric to adult transition.